The G12V mutant melanoma showed a greater level of signalling through the PI3K-AKT pathway by PIM2 phosphorylation, whereas the Q61L mutant showed a greater activity within the MAPK pathway, determined by increased MEK phosphorylation levels (Posch et al., 2016). The gene discussed is AKT1; the disease is melanoma.